Diagnostic and treatment algorithms incorporated predictive values of Galectin-3 (Gal-3) and interleukin-33 (IL-33) in treatment of coronary diseases and heart failure (5, 6) and evaluating prediabetic state (7). The gene discussed is IL33; the disease is coronary artery disorder.